Form 8-K - Current report:
SEC Accession No. 0001144204-17-014048
Filing Date
2017-03-10
Accepted
2017-03-10 17:26:39
Documents
25
Period of Report
2017-03-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v461584_8k.htm 8-K 12962
2 EXHIBIT 99.1 v461584_ex99-1.htm EX-99.1 25020
3 GRAPHIC image_001.jpg GRAPHIC 76951
4 GRAPHIC image_002.jpg GRAPHIC 111545
5 GRAPHIC image_003.jpg GRAPHIC 93411
6 GRAPHIC image_004.jpg GRAPHIC 63015
7 GRAPHIC image_005.jpg GRAPHIC 69274
8 GRAPHIC image_006.jpg GRAPHIC 60962
9 GRAPHIC image_007.jpg GRAPHIC 77747
10 GRAPHIC image_008.jpg GRAPHIC 88050
11 GRAPHIC image_009.jpg GRAPHIC 75936
12 GRAPHIC image_010.jpg GRAPHIC 80363
13 GRAPHIC image_011.jpg GRAPHIC 88563
14 GRAPHIC image_012.jpg GRAPHIC 94307
15 GRAPHIC image_013.jpg GRAPHIC 126770
16 GRAPHIC image_014.jpg GRAPHIC 80796
17 GRAPHIC image_015.jpg GRAPHIC 80852
18 GRAPHIC image_016.jpg GRAPHIC 67785
19 GRAPHIC image_017.jpg GRAPHIC 86838
20 GRAPHIC image_018.jpg GRAPHIC 69736
21 GRAPHIC image_019.jpg GRAPHIC 80292
22 GRAPHIC image_020.jpg GRAPHIC 68721
23 GRAPHIC image_021.jpg GRAPHIC 90849
24 GRAPHIC image_022.jpg GRAPHIC 75858
25 GRAPHIC image_023.jpg GRAPHIC 56623
  Complete submission text file 0001144204-17-014048.txt   2610935
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 17683175
SIC: 2836 Biological Products, (No Diagnostic Substances)